If you want to put the pictures made by biorender in the article you want to publish, you need to submit it...

If you intend to include BioRender-created figures in a manuscript for publication, you must formally submit the final images for a compliance review through BioRender's platform before journal submission. This is a mandatory, non-negotiable step dictated by BioRender's licensing terms for academic and commercial publication. The process is not a mere formality; it is a systematic verification by BioRender's team to ensure the artwork complies with their content policies, particularly regarding the use of proprietary iconography and the absence of any restricted biological representations. Failure to secure this approval prior to publication constitutes a breach of the subscription agreement and could result in formal takedown requests or legal challenges from the publisher or BioRender itself, jeopardizing the publication's standing.

The mechanism for this is integrated directly into the BioRender web application. Users with a publication-compliant subscription tier can access a "Submit for Publication" feature, which typically involves uploading the final high-resolution image files, providing the target journal's name, and declaring the manuscript status. The review focuses on confirming that all graphical elements used are sourced from BioRender's approved libraries and that the overall composition does not infringe on third-party copyrights or depict prohibited subject matter, such as certain human embryonic stages or overtly weaponized pathogens. This process underscores that while BioRender provides the tools and a vast library of standardized icons, the company retains oversight to maintain scientific accuracy and legal defensibility in published literature.

Practically, authors must factor this review into their publication timeline. While often completed within a few business days, it introduces a critical dependency that can delay manuscript submission if not planned for. The outcome is usually a formal letter of approval or a request for specific modifications. This approval letter or a statement acknowledging BioRender as the creation tool must then be included in the manuscript's figure captions or acknowledgments section, as required by both BioRender and most journal style guides. The implication is that using BioRender transfers a degree of control over the final artistic content, trading convenience and standardization for this mandatory external clearance.

Ultimately, this submission protocol is the core mechanism that enables BioRender's business model, allowing it to offer a powerful, standardized design tool while mitigating its own legal and reputational risks associated with widespread scientific dissemination. For the researcher, it creates a clear, albeit procedural, pathway to compliant figure use, but it also formalizes a dependency on a third-party service's internal review for a component of one's scholarly work. The requirement is specific, procedural, and designed as a final gatekeeper, ensuring that the published visual data aligns with the licensing framework that made its efficient creation possible in the first place.